Fact CheckerSign in

NCT06432309Completed

Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease

Efficacy and Safety of Opicapone in Parkinson's Disease Add -on to Levodopa Carbidopa Intestinal Gel

Source: ClinicalTrials.gov · Last updated 3 Mar 2025

Brief summary (registry, in English)

Levodopa-Carbidopa intestinal gel (LCIG) is an effective therapy for complicated Parkinson's disease (PD). Few studies have explored the efficacy and safety of the potential combination of LCIG with catechol-O-methyltransferase (COMT) inhibitors, particularly Opicapone (OPC).

Status (registry)
Completed
Study type
Interventional
Enrollment
22 (actual)
First submitted
7 May 2024
Start date
1 Jul 2022
Primary completion date
31 Dec 2023
Lead sponsor
University Hospital of Ferrara
NCT number
NCT06432309

What you commit to

  • Study type: Interventional
  • Participants enrolled: 22
  • From 1 Jul 2022 to the primary completion date, 31 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Hoehn \& Yahr (H\&Y) \>4,
  • Cognitive decline (MOCA\< 17),
  • more than 30 months after LCIG positioning,
  • not compliant with treatment and follow-up visits.

Who the study is looking for

  • LCIG implantation not longer than 30 months before the study enrollment,
  • Presence of nocturnal akinesia (assessed by medical history and through item 2.9 of MDS-UPDRS part II (\> 2), or/and
  • Persistence of morning or afternoon akinesia (assessed by item 4.3 in MDS UPDRS -IV( \>2 ).

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital of Ferrara - Arcispedale Sant'Anna
Coordinator of this site? Confirm its status
FerraraItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.